Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.06.19
会计师事务所选聘制度(2010年6月)
2010.06.19
关于高级治理职员聘用和告退的通告
2010.06.19
中国建银投资证券有限责任公司关于公司2010年过活常关联生意的核查意见
2010.06.19
关于召开2010年第二次暂时股东大会的通知
2010.06.19
第一届监事会第八次聚会决议通告
2010.06.19
累积投票制实验细则(2010年6月)
2010.06.19
年报信息披露重大过失责任追究制度(2010年6月)
2010.06.19
董事会提名委员会关于聘用治理职员的审核意见
2010.06.19
关于2010年度预计一样平常谋划性关联生意事项的通告
2010.06.19
内部问责制度(2010年6月)
第一页
上一页
148
149
150
151
152
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】